Company intelligence / Profile preview

Zhejiang Garden Bio

Dongyang, Zhejiang, China

Ownership: Private
Employees: ~1100
Development stage: Other

Overview

Zhejiang Garden Bio is a leading global manufacturer of Vitamin D3 and its derivatives, headquartered in Dongyang, China. The company is recognized as the world's largest producer of Vitamin D3, operating a complete vertical industry chain that spans from lanolin and cholesterol to pharmaceutical-grade Vitamin D3 and active vitamin D analogues. Its product portfolio serves the feed, food, and pharmaceutical sectors, with a strategic focus on high-value downstream products like 25-hydroxyvitamin D3, calcitriol, and alfacalcidol. As a publicly traded entity on the Shenzhen Stock Exchange, the company continues to expand its manufacturing capabilities and R&D efforts in metabolic and bone health therapeutics.

Therapeutic areas: Endocrinology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Zhejiang Garden Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhejiang Garden Bio.

Explore the full profile